Grant4

VOLITIONRX LTD

Total Value

Filing Date

Oct 23, 2026

1 transaction

Trade Summary

On Invalid Date, Batchelor Ann-Louise, Insider, reported $0 of VOLITIONRX LTD (VNRX) across 1 transaction. The filing covers Common Stock and reflects balanced net activity of $0. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Insider Information

Name: Batchelor Ann-Louise
Role: Insider
Location: HENDERSON, NV

Filing Details

Filing Date: Oct 23, 2026
Transaction Date: Invalid Date
Accession Number: 0001477932-26-006439
Form Type: 4

Non-Derivative Transactions

Date	Security	Shares	Price	Type	Value
Invalid Date	Common Stock	12,000	—	Grant/Award	—

Want live alerts when Batchelor Ann-Louise trades again?

Download Insider Trades to track VNRX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

iOS App Android App

Footnotes

(F1)On October 21, 2026, the reporting person was awarded 12,000 RSUs under the Issuer's 2026 Stock Incentive Plan. The RSUs vest in full on January 9, 2027 (the "Vesting Date"), subject to the reporting person's continued service through such date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.
(F2)An aggregate of 6,681 of the 7,100 previously reported RSUs awarded under the Issuer's 2024 Stock Incentive Plan will vest on the Vesting Date, subject to the Reporting Person's continued service through such date, and settle for shares of common stock equal to the number of RSUs that have vested. The remaining 419 previously reported RSUs will not vest and will be forfeited. Accordingly, the amount of securities beneficially owned directly in column 5 of Table 1 reflects the forfeiture.
(F3)On April 28, 2026, the Issuer effected a one-for-20 reverse stock split of its issued and outstanding common stock and made proportionate retroactive adjustments to its outstanding equity awards to the extent required including with respect to then-outstanding RSUs (the "Reverse Split"). No fractional shares were issued in connection with the Reverse Split, and each holder who otherwise would have been entitled to receive a fractional share received one whole share of common stock in lieu of such fractional share. Accordingly, the amount of securities beneficially owned directly and indirectly in column 5 of Table 1 has been adjusted to reflect the impact of the Reverse Split.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Batchelor Ann-Louise

(Last)

(First)

(Middle)

1489 WEST WARM SPRINGS ROAD,

SUITE 110

(Street)

HENDERSON

89014

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
VOLITIONRX LTD [ VNRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Group Chief Marketing Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/21/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/21/2026		A		12,000⁽¹⁾	A	$0	27,786⁽²⁾⁽³⁾	D
Common Stock								1,471⁽³⁾	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. On October 21, 2026, the reporting person was awarded 12,000 RSUs under the Issuer's 2026 Stock Incentive Plan. The RSUs vest in full on January 9, 2027 (the "Vesting Date"), subject to the reporting person's continued service through such date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

2. An aggregate of 6,681 of the 7,100 previously reported RSUs awarded under the Issuer's 2024 Stock Incentive Plan will vest on the Vesting Date, subject to the Reporting Person's continued service through such date, and settle for shares of common stock equal to the number of RSUs that have vested. The remaining 419 previously reported RSUs will not vest and will be forfeited. Accordingly, the amount of securities beneficially owned directly in column 5 of Table 1 reflects the forfeiture.

3. On April 28, 2026, the Issuer effected a one-for-20 reverse stock split of its issued and outstanding common stock and made proportionate retroactive adjustments to its outstanding equity awards to the extent required including with respect to then-outstanding RSUs (the "Reverse Split"). No fractional shares were issued in connection with the Reverse Split, and each holder who otherwise would have been entitled to receive a fractional share received one whole share of common stock in lieu of such fractional share. Accordingly, the amount of securities beneficially owned directly and indirectly in column 5 of Table 1 has been adjusted to reflect the impact of the Reverse Split.

	/s/ Ann-Louise Batchelor	10/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Form 4 as rendered by the SEC from accession 0001477932-26-006439.

VOLITIONRX LTD

Trade Summary

Company Information

Insider Information

Filing Details

Non-Derivative Transactions

Want live alerts when Batchelor Ann-Louise trades again?

Footnotes

SEC Form 4

SEC Filing

SEC Form 4